RT Journal Article
SR Electronic
T1 Complete Remission of Ovarian Small Cell Carcinoma Treated with Irinotecan and Cisplatin: A Case Report
JF Anticancer Research
JO Anticancer Res
FD International Institute of Anticancer Research
SP 2685
OP 2687
VO 27
IS 4C
A1 MAKI SAITOH-SEKIGUCHI
A1 KENJI NAKAHARA
A1 TAKANOBU KOJIMAHARA
A1 TSUYOSHI OHTA
A1 JUN KAWAGOE
A1 TSUYOSI OHNUKI
A1 TADASHI HAYASAKA
A1 TEIICHI MOTOYAMA
A1 HIROHISA KURACHI
YR 2007
UL http://ar.iiarjournals.org/content/27/4C/2685.abstract
AB Background: Small cell carcinoma of the ovary is a rare type of ovarian carcinoma with a very poor prognosis. Case Report: We report here a case of a 55-year-old woman with small cell carcinoma of the left ovary. The patient underwent cytoreductive surgery with residual tumors of 6 cm at the cul-de-sac and was found to have stage IIIc disease. After six courses of irinotecan (CPT-11) and cisplatin (CDDP) combination therapy, secondary cytoreductive surgery was performed. The patient showed no evidence of residual tumors. After an additional three courses of chemotherapy, the patient is still alive and well without evidence of disease. Conclusion: CPT-11 and CDDP combination chemotherapy may be effective and safe for patients with small cell carcinoma of the ovary.